REVIEW
Accepted on 27 Oct 2025
Mepolizumab for hypereosinophilic syndrome (HES): effectiveness and safety from real-world evidence
- 131 views
- Frontiers in Immunology
- Inflammation
- Research Topics
- Evolving paradigms: IL-5's role in eosinophilic pathologies and targeted treatments
Evolving paradigms: IL-5's role in eosinophilic pathologies and targeted treatments
14
Total downloads
2,464
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
ORIGINAL RESEARCH
Published on 23 Oct 2025
Benralizumab for adults with rare and off-label eosinophilic disorders: a 52-week prospective, single-center study
doi 10.3389/fimmu.2025.1702989
- 437 views
CASE REPORT
Accepted on 21 Oct 2025
A Potential Novel Treatment for Drug-Induced Acute Interstitial Nephritis: Benralizumab A case presentation
- 329 views
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.